Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating Activities:
Net loss	$ (24,585,177)	$ (1,368,298)
Depreciation expense	14,290	11,063
Amortization of debt discount	769,134	360,599
loss from short-term investment	7,867
Shares issued for services	1,044,144
Finance loss arising from change in terms of convertible notes	21,472,897
Change in derivative liability		(336,272)
Non cash finance, general and administrative expenses arising from settlement with debt and warrant holders		659,960
Employee option expenses		72,495
Decrease in net liabilities for sale	(49,729)
Increase in accounts payable and accrued expenses	13,032	121,939
Decrease in amounts due from related party		(64,372)
Increase in deferred revenues	50,000
Increase in accrued interest		(3,267)
Increase in other receivables	(56,323)	(21,875)
Net cash used in continuing operating activities	(1,319,865)	(615,719)
Investing Activities:
Decrease in restricted cash		11,868
Purchase of fixed assets		(3,438)
Net cash used in investing activities		8,430
Financing Activities:
Proceeds from sale of common stock and warrants (net of issuance expenses)	1,940,950	526,232
Exercise of options	63
Receipt on account of stock		80,000
Issuance of convertible note	100,000
Net cash provided by financing activities	2,041,013	606,232
Net increase (decrease) in cash	721,148	(1,057)
Cash and cash equivalents - beginning of period	2,959	4,486
Cash and cash equivalents - end of period	724,107	3,429
Non-cash transactions:
Increase in deferred revenues against short-term investment	50,000
Issuance of shares in respect of proceeds received during 2017	(80,000)
Common stock issued pursuant to convertible note	85,218
Issuance of Preference Shares in connection with settlement with debt and warrant holders		529,000
Settlement agreement with debt and warrant holders accounted for as extinguishment and re issuance of debt:
Extinguishment of convertible note		(470,200)
Re issuance of convertible note		$ 606,160